Sales rise 130.24% to Rs 7.69 crore
Net profit of Beryl Drugs reported to Rs 0.34 crore in the quarter ended September 2022 as against net loss of Rs 0.42 crore during the previous quarter ended September 2021. Sales rose 130.24% to Rs 7.69 crore in the quarter ended September 2022 as against Rs 3.34 crore during the previous quarter ended September 2021. ParticularsQuarter EndedSep. 2022Sep. 2021% Var.Sales7.693.34 130 OPM %8.06-2.99 -PBDT0.51-0.21 LP PBT0.32-0.45 LP NP0.34-0.42 LPPowered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
